Clincosm LogoSign in Get a demo

Neuropsychological and Psychosocial Follow up of Children and Adolescents With Neuromuscular Disease

Sponsor
Universitaire Ziekenhuizen Leuven (Other)
Overall Status
Unknown status
CT.gov ID
NCT02253290
Collaborator
(none)
300
Enrollment
1
Location
64
Duration (Months)
4.7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This project is a retrospective and prospective investigation of neuropsychological and psychosocial development of children with a neuromuscular disease.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This project is a retrospective and prospective investigation of neuropsychological and psychosocial development of children with a neuromuscular disease. Children and adolescents in UZ Leuven will be evaluated according to a psychosocial and neuropsychological protocol including different psychological tests and patient questionaires.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    300 participants
    Observational Model:
    Cohort
    Official Title:
    Neuropsychological and Psychosocial Follow up of Children and Adolescents With Neuromuscular Disease
    Study Start Date :
    Dec 1, 2014
    Anticipated Primary Completion Date :
    Apr 1, 2020
    Anticipated Study Completion Date :
    Apr 1, 2020

    Arms and Interventions

    Arm Intervention/Treatment
    Neuromuscular disease

    Children and adolescents with Neuromuscular disease children according to neuromuscular convention UZL

    Outcome Measures

    Primary Outcome Measures

    1. Neuropsychological profile (questionnaires, neuropsychological testing) of children with myotonic dystonia type 1 [one year]

      Compare the outcome of the questionnaires, IQ test and other neuropsychological test to a normal population

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion criteria

    • children and adolescents (0-18 years)

    • diagnosis of neuromuscular disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UZ Leuven Leuven Belgium 3000

    Sponsors and Collaborators

    • Universitaire Ziekenhuizen Leuven

    Investigators

    • Principal Investigator: Nathalie Goemans, MD, PhD, UZ Leuven
    • Principal Investigator: Liesbeth De Waele, MD, PhD, UZ Leuven

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Universitaire Ziekenhuizen Leuven
    ClinicalTrials.gov Identifier:
    NCT02253290
    Other Study ID Numbers:
    • S57182
    First Posted:
    Oct 1, 2014
    Last Update Posted:
    Aug 21, 2015
    Last Verified:
    Aug 1, 2015
    Additional relevant MeSH terms:
    Neuromuscular Diseases

    Study Results

    No Results Posted as of Aug 21, 2015